Dr. Jill Schofield Publications

Schofield, J. R., & Hassell, K. L. (2023). What you need to know about migraine in Hughes syndrome patients. Lupus, 09612033231153790.

Schofield, J. R. (2021). Persistent antiphospholipid antibodies, mast cell activation syndrome, postural orthostatic tachycardia syndrome and post-COVID syndrome: 1 year on. European Journal of Case Reports in Internal Medicine, 8(3).

Lawrence B Afrin, Mary B Ackerley, Linda S Bluestein… Jill R Schofield… Mark Westaway, Shijun Cindy Xi, and Gerhard J Molderings. 2020. Diagnosis of Mast Cell Activation Syndrome: A Global “Consensus-2.” Diagnosis 1.

Jill R Schofield and Lawrence B. Afrin. 2019. Recognition and Management of Medication Excipient Reactivity in Patients with Mast Cell Activation Syndrome. The American Journal of the Medical Sciences 357 (6): 507-511.

Jill R Schofield and Kamal R. Chemali. 2019. Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 Patients. American Journal of Therapeutics 26 (5): e570-e582. 

Jill R Schofield, Alan G. Palestine, Victoria Pelak, and Marc T. Mathias. 2019. Deep Capillary Retinal Ischemia and High-Titer Prothrombin-Associated Antiphospholipid Antibodies: A Case Series of Three Patients. American Journal of Ophthalmology Case Reports 14: 105-109.

Jill R Schofield and Jeanne E. Hendrickson. 2018. Autoimmunity, Autonomic Neuropathy, and the HPV Vaccination: A Vulnerable Subpopulation. Clinical Pediatrics 57 (5): 603-606. 

Jill R Schofield and K. Hassell. 2018. Dosing Considerations in the Use of the Direct Oral Anticoagulants in the Antiphospholipid Syndrome. Journal of Clinical Pharmacy and Therapeutics 43 (1): 104-106. 

Jill R Schofield and Kamal R. Chemali. 2018. How We Treat Autoimmune Small Fiber Polyneuropathy with Immunoglobulin Therapy. European Neurology 80 (5-6): 304-310. 

Jill R Schofield. 2017. Autonomic Neuropathy—In Its Many Guises—As the Initial Manifestation of the Antiphospholipid Syndrome. Immunologic Research, 65 (2): 532-542. 

Jill R Schofield, S Blitshteyn, Y Shoenfeld, and GRV Hughes. 2014. Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospolipid (Hughes) syndrome (APS). Lupus 0: 1-6.

Jill R Schofield. 2014. Case 9-2014: A Woman with Increasing Dyspnea. The New England Journal of Medicine 371 (4):387-388.

Jill R Schofield and William A. Robinson. 1995. A New Myeloproliferative Syndrome. American Journal of Hematology 48 (3): 186-191.

Jill R Schofield and William A. Robinson. 1995. Low-Dose Interferon-α in Chronic Myeloid Leukemia. Annals of Internal Medicine 122 (9): 728-729.

Jill R Schofield, William A. Robinson, James R. Murphy, and Douglas K. Rovira. 1994. Low Doses of Interferon-Α Are as Effective as Higher Doses in Inducing Remissions and Prolonging Survival in Chronic Myeloid Leukemia. Annals of Internal Medicine 121 (10): 736-744.

Jill R Schofield, Hughes HN, Birlea M, and Hassell KL. 2021. A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients. Lupus 30 (4): 568-577.

Kesterson K, Jill R Schofield, and Blitshteyn S. 2023. Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with Postural Orthostatic Tachycardia Syndrome (POTS). Journal of Neurology 270 (1): 233-239.

Jill R Schofield, Brook J, and Calaprice-Whitty D. 2024. Elevated total serum IgM predicts the presence of antiphospholipid antibodies in dysautonomia patients. Immunologic Research 72 (5): 1086-1091.

Chemali K, Blitshteyn S, Perez JA, and Jill R Schofield. 2024. iSTAND trial of IVIG in POTS: a step in the right direction, but more studies are needed. Clinical Autonomic Research.

Blitshteyn S, Treisman GJ, Ruhoy IS, Saperstein DS, Jill R Schofield, Goodman BP, Davenport TE, Cutchins AC, and Grubb BP. 2024. POTS and other autonomic disorders are not "functional" and are not comorbid with functional neurologic disorder. Frontiers in Neurology.

Weinstock LB, Afrin LB, Reiersen AM, Brook J, Blitshteyn S, Erlich G, Jill R Schofield, Kinsella L, Kaufman D, Dempsey T, and Molderings GJ. 2025. Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndrome. Brain, Behavior and Immunity 48.

Afrin LB, Weinstock LB, Dempsey TT, Aschenbrenner K, Blitshteyn S, and Jill R Schofield. 2025. Utility of Glucagon-Like-Peptide-1-Receptor Agonists in Mast Cell Activation Syndrome. American Journal of the Medical Sciences.